Polyvascular extracoronary atherosclerotic disease in patients with coronary artery disease

Tadeusz Przewłocki1, Anna Kabłak-Ziembicka, Artur Kozanecki

  • 1Department of Cardiac and Vascular Diseases, Institute of Cardiology, Jagiellonian University Collegium Medicum, The John Paul II Hospital, Krakow, Poland. tadeuszprzewlocki@op.pl

Kardiologia Polska
|September 29, 2009
PubMed

Insights

Significant atherosclerosis affects 36% of patients with coronary artery disease (CAD). Factors like smoking, high creatinine, and female gender predict polyvascular atherosclerosis (PVA) in these patients.

Area of Science:

  • Cardiovascular Medicine
  • Atherosclerosis Research
  • Vascular Disease Epidemiology

Background:

  • Cardiovascular diseases are a leading cause of death globally, with increasing prevalence of coronary artery disease (CAD), peripheral arterial disease (PAD), supra-aortic arterial disease (SAD), and renal stenosis (RAS).
  • Polyvascular atherosclerosis (PVA), affecting multiple arterial territories, significantly worsens cardiovascular outcomes.

Purpose of the Study:

  • To investigate the prevalence, coexistence, and predictors of significant PAD, SAD, and RAS in individuals suspected of having CAD.
  • To understand the extent of atherosclerosis beyond the coronary arteries in a patient cohort undergoing coronary angiography.

Main Methods:

  • Analysis of angiography data from 687 consecutive patients (mean age 63.5 years) undergoing coronary angiography.
  • Stenosis of >=50% in CAD, SAD, PAD, and RAS was quantified.
  • Logistic regression analysis identified independent predictors of multi-territory PVA.

Main Results:

  • Significant CAD was detected in 79.3% of patients.
  • Extracoronary atherosclerosis was prevalent: SAD in 19.8%, RAS in 8%, and PAD in 15%.
  • Independent predictors for at least 2-territory PVA included multivessel CAD, hyperlipidemia, smoking, elevated creatinine, lower extremity claudication, and female gender.

Conclusions:

  • A substantial proportion (36%) of patients with documented CAD also exhibit significant atherosclerosis in extracoronary arteries.
  • The presence and severity of PVA correlate with an increased burden of atherosclerosis risk factors and a history of atherothrombotic events.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...